Ali Marwa A, Hussein Sherin Khamis, Khalifa Abeer A, El Amin Ali Amani M, Farhan Marwa S, Ibrahim Amin Amal A, Mohamed Esam Ali
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Department of Paediatrics, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Front Mol Biosci. 2022 Oct 12;9:1007347. doi: 10.3389/fmolb.2022.1007347. eCollection 2022.
is a long noncoding RNA that works as an enhancer for the Interferon-gamma (IFN-γ) transcript. (growth arrest-specific 5) is a lncRNA that is associated with glucocorticoid resistance. Aberrant expressions of and are directly linked to numerous autoimmune disorders but their levels in childhood ITP are still obscure. This study aims to elucidate expressions of target lncRNAs in childhood ITP and their association with pathophysiology and clinical features of the disease as well as their association with types and treatment responses. The fold changes of target lncRNAs in blood samples from children with ITP and healthy controls were analyzed using quantitative real-time PCR (qRT-PCR). There were overexpressed lncRNAs and in serum of childhood ITP patients [(median (IQR) = 3.08 (0.2-22.39) and 4.19 (0.9-16.91) respectively, Also, significant higher and ( < 0.05) were present in persistent ITP (3-12 months) [ median (IQR) = 4.58 (0.31-22.39) and 3.77 (0.87-12.36) respectively] or chronic ITP (>12 months) [ median (IQR) = 5.6 (0.25-12.59) and 5.61 (1.15-16.91) respectively] when compared to newly diagnosed <3 months patients [ median (IQR) = 1.21 (0.2-8.95), and median (IQR) = 1.07 (0.09-3.55)]. Also, significant higher lncRNAs and were present in patients with partial response to treatment [ median (IQR) = 4.15 (0.94-19.25), and (median (IQR) = 4.25 (0.81-16.91)] or non-response [ median (IQR) = 4.19 (1.25-22.39) and median (IQR) = 5.11 (2.34-15.27)] when compared to patients who completely responded to treatment ( median (IQR) = 2.09 (0.2-14.58) and (median (IQR) = 2.51 (0.09-10.33). In addition, following therapy, the expressions of and are significantly negatively correlated with platelet count. Findings suggest that lncRNAs and are novel diagnostic and prognostic genetic markers for childhood ITP that can aid in a precise prediction of the disease's progress at the time of diagnosis and could be a useful tool for treatment planning.
是一种长链非编码RNA,作为干扰素-γ(IFN-γ)转录本的增强子发挥作用。(生长停滞特异性5)是一种与糖皮质激素抵抗相关的长链非编码RNA。和的异常表达与多种自身免疫性疾病直接相关,但其在儿童免疫性血小板减少症(ITP)中的水平仍不清楚。本研究旨在阐明儿童ITP中靶长链非编码RNA的表达及其与疾病病理生理学和临床特征的关系,以及它们与疾病类型和治疗反应的关系。使用定量实时PCR(qRT-PCR)分析ITP患儿和健康对照者血样中靶长链非编码RNA的倍数变化。儿童ITP患者血清中的长链非编码RNA和表达上调[中位数(四分位间距)分别为3.08(0.2 - 22.39)和4.19(0.9 - 16.91)]。此外,持续性ITP(3 - 12个月)[中位数(四分位间距)分别为4.58(0.31 - 22.39)和3.77(0.87 - 12.36)]或慢性ITP(>12个月)[中位数(四分位间距)分别为5.6(0.25 - 12.59)和5.61(1.15 - 16.91)]中,与新诊断<3个月的患者相比[中位数(四分位间距)= 1.21(0.2 - 8.95),中位数(四分位间距)= 1.07(0.09 - 3.55)],和显著更高(<0.05)。同样,与完全缓解的患者相比[中位数(四分位间距)= 2.09(0.2 - 14.58),中位数(四分位间距)= 2.51(0.09 - 10.33)],部分缓解[中位数(四分位间距)= 4.15(0.94 - 19.25),中位数(四分位间距)= 4.25(0.81 - 16.91)]或无反应[中位数(四分位间距)= 4.19(1.25 - 22.39),中位数(四分位间距)= 5.11(2.34 - 15.27)]的患者中和显著更高。此外,治疗后,和的表达与血小板计数显著负相关。研究结果表明,长链非编码RNA和是儿童ITP新的诊断和预后遗传标志物,有助于在诊断时精确预测疾病进展,并且可能是治疗规划的有用工具。